CD16-IL15-EpCAM TriKE

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCD16-IL15-EpCAM TriKE

Drug Alias Namenext-generation TriKE (GT Biopharma)Anti-CD16/anti-EpCAM/IL-15 trispecific NK-cell engager (GT Biopharma)Anti-CD16/anti-EpCAM/IL-15 trispecific immune-cell engager (GT Biopharma)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionEpithelial cell adhesion molecule modulatorsLow affinity immunoglobulin gamma Fc region receptor III agonistsInterleukin-15 receptors agonists

TargetsInterleukin-15 receptorsLow affinity immunoglobulin gamma Fc region receptor IIIEpithelial cell adhesion molecule

Therapy Area/IndicationsHead and Neck Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGt Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGt Biopharma Inc

Active IndicationsN/A

Inactive IndicationsHead and Neck Neoplasms

Other Information

ATC CodeN/A